Ponatinib (AP24534)

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

Customer Product Validation(2)

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellM4S2Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDpd2xQUUN3ME2wMlAxODByMECzOVkh|ryPM3LSNHNCVkeHUh?=
MV-4-11NW\0epp7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\0TWM2OD1yLkCwNFA6PTZizszNNV\ucFY2W0GQR1XS
MEG-01NE\1cJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEn6c4pKSzVyPUCuNFAxOTJ6IN88US=>NVzEZYFuW0GQR1XS
LAMA-84NF3H[4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3P5fWlEPTB;MD6wNFAyPjVizszNNVPjOWRqW0GQR1XS
CGTH-W-1NHzz[3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvRTWM2OD1yLkCwNVY6KM7:TR?=M2jme3NCVkeHUh?=
KASUMI-1NVXXd4lqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG[zNnhKSzVyPUCuNFAzOTdizszNNHviUGRUSU6JRWK=
BE-13MkLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoTGTWM2OD1yLkCwNlU6KM7:TR?=Mn\KV2FPT0WU
CTV-1M3[zb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3GSHZ7UUN3ME2wMlAxPTJzIN88US=>M{PjZ3NCVkeHUh?=
NKM-1NUX2[VQxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTBwMEC2OVUh|ryPNHPzfo1USU6JRWK=
MONO-MAC-6MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofhTWM2OD1yLkCwPFM4KM7:TR?=MmHHV2FPT0WU
A204M3LCUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonuTWM2OD1yLkCxNlE5KM7:TR?=NYPWSIpxW0GQR1XS
GDM-1NWH0[206T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX35bHBwUUN3ME2wMlAyQDN|IN88US=>M4n6XHNCVkeHUh?=
AN3-CANEHOT4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjrTWM2OD1yLkCxPFc{KM7:TR?=MV\TRW5ITVJ?
BL-70NHHqO25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{TSPWlEPTB;MD6wNlE6QSEQvF2=NEm1dZdUSU6JRWK=
DaudiNHqwPYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVLJR|UxRTBwMEK1N|ch|ryPM1zJenNCVkeHUh?=
KU812NUDSbGc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTBwMEK4OFgh|ryPNEL4TIpUSU6JRWK=
KG-1NIK2c3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXK0XWx[UUN3ME2wMlA{Ojl2IN88US=>NGT6SFRUSU6JRWK=
DOHH-2MnvSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DLTWlEPTB;MD6wOFgxOyEQvF2=NYraR2g6W0GQR1XS
HuO9M3rX[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTBwMEW0OFgh|ryPNEjBWIhUSU6JRWK=
EB2MoXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTBwMEW1O|Yh|ryPNXu2c3BCW0GQR1XS
G-402MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwME[zOFEh|ryPMWnTRW5ITVJ?
SU-DHL-1NYrScW5LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfBTWFKSzVyPUCuNFY{PzlizszNNYHQeG1oW0GQR1XS
NCI-H719MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{W2fGlEPTB;MD6wO|g5QCEQvF2=MUjTRW5ITVJ?
MLMANX\kWGZLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTBwMEmwOkDPxE1?MlHXV2FPT0WU
KM12MnPCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTBwMEm3N|ch|ryPMWLTRW5ITVJ?
SUP-T1NIDRWYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUe3doNCUUN3ME2wMlA6QTh{IN88US=>MknYV2FPT0WU
MZ1-PCNYjSR4VMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTBwMUGzN|Yh|ryPNWX2ZVdjW0GQR1XS
MFE-296M1;rfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYWy[5VWUUN3ME2wMlEyQDN7IN88US=>MkHFV2FPT0WU
ALL-POMXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYG5PIpSUUN3ME2wMlEzPDR|IN88US=>NF\3fWFUSU6JRWK=
GB-1M3rPN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;6TWM2OD1yLkGyOVEzKM7:TR?=MmTKV2FPT0WU
SIG-M5NH\XbFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXiTWM2OD1yLkGzN|ch|ryPMXPTRW5ITVJ?
P30-OHKMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjVTWM2OD1yLkG1OlczKM7:TR?=NHzZdZhUSU6JRWK=
NCI-H716M1\DN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MljFTWM2OD1yLkG2NlY3KM7:TR?=M13r[XNCVkeHUh?=
MPP-89MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlTiTWM2OD1yLkG2PVM{KM7:TR?=M1roSHNCVkeHUh?=
SF126MlXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2TQbGlEPTB;MD6xO|A3OyEQvF2=NHfWbI1USU6JRWK=
CTB-1NYnyVolIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moq5TWM2OD1yLkG3N|E3KM7:TR?=NVP6S2ZTW0GQR1XS
CA46NW\kbpFrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2rn[GlEPTB;MD6xO|Q5QSEQvF2=NF\FfHFUSU6JRWK=
NCI-H520Ml\FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHFTWM2OD1yLkG3O|MzKM7:TR?=MkPjV2FPT0WU
CAL-85-1NH;NZWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnJS3dKSzVyPUCuNVc6OjdizszNMnS1V2FPT0WU
NCI-H2342MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrl[4NKSzVyPUCuNVg2PzdizszNMYLTRW5ITVJ?
697MkW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHXM[25KSzVyPUCuNVg5PzFizszNNXT5[3NPW0GQR1XS
NYNXPNVINiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmruTWM2OD1yLkG5Nlg4KM7:TR?=M3L6SHNCVkeHUh?=
T98GMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3HLZmlEPTB;MD6xPVMyQCEQvF2=NUOxZ5gxW0GQR1XS
NCI-H1703Mlz5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTBwMUm2NVUh|ryPNW[xUGI5W0GQR1XS
NCI-H2087NWTxWmF{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LJOGlEPTB;MD6yNFQ{QSEQvF2=MXrTRW5ITVJ?
PF-382MkHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3sTWM2OD1yLkKwPFc{KM7:TR?=M4D0OnNCVkeHUh?=
HCT-116MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwMkGwOlkh|ryPNG\OTnNUSU6JRWK=
CAKI-1NISzWGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NECyWYhKSzVyPUCuNlE3PjZizszNM3nM[nNCVkeHUh?=
CCF-STTG1MnKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;yOmlEPTB;MD6yNlQ4PSEQvF2=MWDTRW5ITVJ?
D-392MGNEW4SlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUK5W2VqUUN3ME2wMlI{OTd5IN88US=>M1;oXnNCVkeHUh?=
RT-112M4\5Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mke2TWM2OD1yLkKzO|k2KM7:TR?=NED6Wo9USU6JRWK=
MES-SAMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTBwMkSxPFch|ryPMnnnV2FPT0WU
LC-2-adNF7Zd4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjQTWM2OD1yLkK0NlY2KM7:TR?=NXPtRVJEW0GQR1XS
NOS-1M{n2XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1i3[mlEPTB;MD6yOFM3PyEQvF2=MVvTRW5ITVJ?
NALM-6MkL5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M37zcmlEPTB;MD6yOVU1OyEQvF2=MVTTRW5ITVJ?
TE-15MnnmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MonUTWM2OD1yLkK2NFkyKM7:TR?=NFfS[nNUSU6JRWK=
786-0M17ON2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkfxTWM2OD1yLkK2NlI5KM7:TR?=M2i1bnNCVkeHUh?=
IST-MES1NXOwVY5UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLnTWM2OD1yLkK2PFI6KM7:TR?=MoXqV2FPT0WU
KYSE-180MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{Dn[WlEPTB;MD6yOlg6OSEQvF2=MXvTRW5ITVJ?
YTMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1PjfmlEPTB;MD6yOlk4PCEQvF2=NXGxWmt6W0GQR1XS
A427MmKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkmxTWM2OD1yLkK3NlY1KM7:TR?=NHWxeFhUSU6JRWK=
KYSE-450MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTBwMkezNlkh|ryPNXPI[GVjW0GQR1XS
HuH-7MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\IemRqUUN3ME2wMlI4PzZ|IN88US=>M1jzVHNCVkeHUh?=
CAS-1NHHDb3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTBwMkizNFMh|ryPNVz2S|RvW0GQR1XS
KURAMOCHINHi2UJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHxTWM2OD1yLkK4OFE6KM7:TR?=NYXoeWVHW0GQR1XS
ACHNMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzVWZZKSzVyPUCuNlk{OjNizszNNHHNNFlUSU6JRWK=
HGC-27MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnPDTWM2OD1yLkK5N|U{KM7:TR?=M2fHV3NCVkeHUh?=
A172NEjOd41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTBwMkm1O|ch|ryPMVPTRW5ITVJ?
SNU-449M4TXOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPj[nZKSzVyPUCuNlk6PjRizszNM2\YUHNCVkeHUh?=
SW982NELofmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{P2cGlEPTB;MD6yPVk4QCEQvF2=NIjGPW9USU6JRWK=
EFO-21MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\ETWM2OD1yLkOwOFEyKM7:TR?=M3[3PHNCVkeHUh?=
NCI-H2030NUnJU25GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXMS3o6UUN3ME2wMlMyOTZ2IN88US=>M2fr[nNCVkeHUh?=
HT-144NIDzRY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUj3[I5[UUN3ME2wMlMyOjhizszNNWq2c3BsW0GQR1XS
MFE-280MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVT1fnU1UUN3ME2wMlMyPDV|IN88US=>NHzVS5lUSU6JRWK=
SK-LU-1NUTrWpQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XEXGlEPTB;MD6zNVQ3PiEQvF2=NUPVRmxOW0GQR1XS
NCI-H2052NVPSd3YzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTBwM{G0PFQh|ryPNWX6[5Z[W0GQR1XS
SK-HEP-1MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUPJR|UxRTBwM{OzOlgh|ryPMmjBV2FPT0WU
QIMR-WILM3f2emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLGR2hDUUN3ME2wMlM{PDJ2IN88US=>Mn;iV2FPT0WU
A2780NHHCUFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDlW2NlUUN3ME2wMlM1OzB2IN88US=>NGPWNm1USU6JRWK=
ACNMlTkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWTJR|UxRTBwM{S4O|Mh|ryPNVfvXGhuW0GQR1XS
BxPC-3M3z4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTBwM{S5PFkh|ryPNXfudoR4W0GQR1XS
BCPAPMoDjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17qXWlEPTB;MD6zOlAxOSEQvF2=MUfTRW5ITVJ?
HOP-62M2W3c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHPWbGFKSzVyPUCuN|YyODZizszNMVXTRW5ITVJ?
SW1710NHrqc4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYPHRm5VUUN3ME2wMlM3PDV3IN88US=>NEmzeotUSU6JRWK=
OPM-2MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHr[mwyUUN3ME2wMlM3PDd|IN88US=>MVTTRW5ITVJ?
DBTRG-05MGMnvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXXJR|UxRTBwM{iwOVQh|ryPNIHsNG9USU6JRWK=
SK-MEL-24Ml\CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmGxTWM2OD1yLkO5O|kyKM7:TR?=MmLVV2FPT0WU
8305CNYnHfo42T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVrJR|UxRTBwM{m3PVMh|ryPMlnWV2FPT0WU
OVCAR-4M3\UN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnpNVdKSzVyPUCuOFE2QDZizszNNIfZUYFUSU6JRWK=
HLEM2PYVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NITFZ2RKSzVyPUCuOFE5PiEQvF2=MnW0V2FPT0WU
NCI-H747NH3DflFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWfJR|UxRTBwNEKxN|ch|ryPNFX0TmdUSU6JRWK=
SW780Mom2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\2TWM2OD1yLkSyN|Q3KM7:TR?=NGjNWlVUSU6JRWK=
KYSE-150MmfHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWi4eoRVUUN3ME2wMlQzPDF3IN88US=>MoWyV2FPT0WU
H4M1n2RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2S5emlEPTB;MD60NlQ2OSEQvF2=MmS2V2FPT0WU
SW1088MoTES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPPPINSUUN3ME2wMlQ1OzlizszNNIjXcoFUSU6JRWK=
SF268MkjYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{H1fWlEPTB;MD60OFg3KM7:TR?=MVPTRW5ITVJ?
RT4M2L0fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRTBwNEWxNVEh|ryPMo\HV2FPT0WU
NCI-H522NWnre41XT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTBwNEWyO{DPxE1?MoDFV2FPT0WU
LCLC-97TM1M2TZdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnyyTWM2OD1yLkS2NVk2KM7:TR?=MlS2V2FPT0WU
CAL-39NXfSVFFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LtXWlEPTB;MD60OlUyQSEQvF2=MoTiV2FPT0WU
CAL-120M4jJS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3PqXWlEPTB;MD60O|Y1OyEQvF2=MlrSV2FPT0WU
ESS-1M1vUdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnGzTWM2OD1yLkS3PFIyKM7:TR?=NIj0dVlUSU6JRWK=
KARPAS-45Mkn1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{[1XGlEPTB;MD60PFk{OyEQvF2=M2rLVXNCVkeHUh?=
DU-4475MnjmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrlTWM2OD1yLkS5OVEyKM7:TR?=NFuzVlVUSU6JRWK=
VMRC-RCZMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFn3RmVKSzVyPUCuOFk6ODRizszNMUTTRW5ITVJ?
HOSM1zBT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTBwNUCzOlUh|ryPM{PRZ3NCVkeHUh?=
MOLT-16MmX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRTBwNUG4NFgh|ryPMYPTRW5ITVJ?
RPMI-6666NV;rc4hFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwNUKxN|Uh|ryPM{\2fXNCVkeHUh?=
K052NW\ONXhoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPDVHR4UUN3ME2wMlUzOTRizszNNV:wSVRYW0GQR1XS
EHEBNYnOeHFuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTBwNUKxPFIh|ryPNWL4fmw2W0GQR1XS
MFH-inoNWTLZpJqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTBwNUKzOVEh|ryPMWLTRW5ITVJ?
A4-FukNH\GR49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUPTToNXUUN3ME2wMlUzPTJ6IN88US=>MVPTRW5ITVJ?
SW1417NIjT[I9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4PJPWlEPTB;MD61Nlc5OSEQvF2=NIfneVlUSU6JRWK=
DoTc2-4510MlHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\2NGlEPTB;MD61OFk2QCEQvF2=NXTVVY03W0GQR1XS
TE-12M33FU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonxTWM2OD1yLkW1O|M2KM7:TR?=NV\ifJR{W0GQR1XS
8-MG-BANV\1RlZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUfBVXBJUUN3ME2wMlU3ODV4IN88US=>NFXLfJhUSU6JRWK=
ECC12MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnqwTWM2OD1yLkW2OVU5KM7:TR?=Mn7kV2FPT0WU
CHL-1M4q2VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTBwNUe0OlMh|ryPMmXxV2FPT0WU
LCLC-103HM{DH[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXiTYpKSzVyPUCuOVg{PDRizszNMYLTRW5ITVJ?
OS-RC-2MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTBwNUizO|kh|ryPM1y4T3NCVkeHUh?=
RO82-W-1NIGxb4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTBwNUm2NVUh|ryPM1XNSHNCVkeHUh?=
A3-KAWMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HVdmlEPTB;MD62NVQ3PyEQvF2=MmnjV2FPT0WU
NCCITM4\0XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGHFVphKSzVyPUCuOlE4OTVizszNM3jRe3NCVkeHUh?=
IST-SL2NVfkVZR1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXWNlhKSzVyPUCuOlI2OjJizszNNUPwVFE{W0GQR1XS
GI-ME-NNIjaO3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn7NTWM2OD1yLk[zNFY6KM7:TR?=MmLJV2FPT0WU
ES6MmCwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWPPNIpLUUN3ME2wMlY{Ojl3IN88US=>MUfTRW5ITVJ?
BL-41MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2T2OWlEPTB;MD62N|M2OiEQvF2=NYfofYtKW0GQR1XS
Ca-SkiMmjlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LCUmlEPTB;MD62OFgyKM7:TR?=M3XD[3NCVkeHUh?=
HOP-92NIDVS5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTzTWM2OD1yLk[1OlczKM7:TR?=MlywV2FPT0WU
SK-LMS-1NYnUS5RLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jIVGlEPTB;MD62OlQ4KM7:TR?=NH3WTotUSU6JRWK=
EW-13NGm2THBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTz[phJUUN3ME2wMlY3Pzd7IN88US=>NFzw[JBUSU6JRWK=
647-VMlz3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYjqR4NOUUN3ME2wMlY5OTR6IN88US=>MkHEV2FPT0WU
JiyoyeP-2003MmDBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfwTWM2OD1yLk[5O|M5KM7:TR?=MVjTRW5ITVJ?
WSU-NHLNECxSFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTBwN{C4PFch|ryPM2LafHNCVkeHUh?=
U-698-MMkSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTaSGIzUUN3ME2wMlcyODZ|IN88US=>NH[yTXBUSU6JRWK=
HC-1NV\zSXdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1PUVmlEPTB;MD63NlQxPSEQvF2=NGnpO4NUSU6JRWK=
8505CMor4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfRTWM2OD1yLkeyO|QyKM7:TR?=MXXTRW5ITVJ?
HUTU-80MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHzKN2JKSzVyPUCuO|M{PDlizszNNGrWNW5USU6JRWK=
LB1047-RCCM2PKVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1[xeGlEPTB;MD63N|U{QCEQvF2=NEP3SllUSU6JRWK=
GAMGM13ORmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPDdlRKSzVyPUCuO|M3PTNizszNMX7TRW5ITVJ?
CAL-12TM3vRVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUizfIlOUUN3ME2wMlc{QDd5IN88US=>NV\wbGZQW0GQR1XS
NCI-SNU-1NFLSU5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXXBdm1oUUN3ME2wMlc4Ojd6IN88US=>NWj0THNxW0GQR1XS
HTC-C3MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnH3TWM2OD1yLke3OFUyKM7:TR?=NFLsPFZUSU6JRWK=
HPAF-IINGf3bHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUT0UVEyUUN3ME2wMlc4PTBzIN88US=>NYDze5FVW0GQR1XS
KGNNF3PUFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVv2N4ZPUUN3ME2wMlc5ODhzIN88US=>Ml7aV2FPT0WU
EFO-27MorvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3TtPWlEPTB;MD63PFc{OyEQvF2=MlzVV2FPT0WU
MEL-HOM4\QWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTBwN{m0OFkh|ryPM4PzUnNCVkeHUh?=
KYSE-270NFXF[5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jaRWlEPTB;MD64NFUzQSEQvF2=NHXRZ3hUSU6JRWK=
NCI-H1755MlPIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\HTWM2OD1yLkiwO|E1KM7:TR?=MkS4V2FPT0WU
MFM-223MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1r1NWlEPTB;MD64NVQxPyEQvF2=M362NnNCVkeHUh?=
G-361MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmjCTWM2OD1yLkixPFk4KM7:TR?=NX\yUnBwW0GQR1XS
ETK-1MlKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYrNSJBUUUN3ME2wMlgzPDRzIN88US=>MYLTRW5ITVJ?
LU-99AMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHnTWM2OD1yLki0O|AyKM7:TR?=M1;udXNCVkeHUh?=
IST-MEL1NVv0fIlLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTBwOEW3N|Ih|ryPNXq3dVJzW0GQR1XS
L-540MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnLITWM2OD1yLki1PFAyKM7:TR?=MWLTRW5ITVJ?
U-2-OSMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTBwOEW4OFYh|ryPM17qSHNCVkeHUh?=
HT-1376NHz4Z5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rVUGlEPTB;MD64OlA2OSEQvF2=MkHRV2FPT0WU
COLO-680NNUnmUZM4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTBwOEe5N|Mh|ryPMYnTRW5ITVJ?
NCI-H1581MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\pNGlEPTB;MD64PVI6PyEQvF2=MVzTRW5ITVJ?
HuCCT1NIXWRVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTBwOEm1OFgh|ryPNGrO[5dUSU6JRWK=
BB30-HNCM4DNcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTBwOUK0Olkh|ryPNGHuNZpUSU6JRWK=
NCI-H2347MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjrbY5nUUN3ME2wMlk{Ojl{IN88US=>M3P0cHNCVkeHUh?=
G-401M3\vWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MliwTWM2OD1yLkmzOlk2KM7:TR?=MXPTRW5ITVJ?
NCI-H358NX;MdlFNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVfJR|UxRTBwOUWwNVQh|ryPNFHIWIFUSU6JRWK=
HCC1395NF[yboJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvETWM2OD1yLkm1OFYyKM7:TR?=NX;1eWN[W0GQR1XS
J82NXX4eYtlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYf1OmllUUN3ME2wMlk2PTR|IN88US=>M4fOOXNCVkeHUh?=
KE-37MlewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3zWXmlEPTB;MD65OlM5PyEQvF2=M1rVUHNCVkeHUh?=
NOMO-1NYnKZ5R{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljQTWM2OD1yLkm2OVY1KM7:TR?=MV3TRW5ITVJ?
ML-2MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTBwOUm3OUDPxE1?M1jyOnNCVkeHUh?=
SW872NVm1R2RwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTBwOUm3O|Uh|ryPMo\QV2FPT0WU
KYSE-520NHLwO4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1HpfWlEPTB;MT6wNFQ6PCEQvF2=MnftV2FPT0WU
HL-60MmjyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M13ocGlEPTB;MT6wNFk4KM7:TR?=M4nMcXNCVkeHUh?=
HDLM-2NFP1VWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{D2XWlEPTB;MT6wNVI2OiEQvF2=NVfnRnZ[W0GQR1XS
MIA-PaCa-2NGLScXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1e5WmlEPTB;MT6wNVM4PSEQvF2=M1\B[nNCVkeHUh?=
TCCSUPMlnoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jHO2lEPTB;MT6wNVc{OiEQvF2=MnzMV2FPT0WU
SH-4MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MljQTWM2OD1zLkCyNlQ1KM7:TR?=NYH1dlA6W0GQR1XS
MG-63M3HOXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTFwMEK2NVYh|ryPMnrpV2FPT0WU
NB6MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTFwMEOxNFkh|ryPMXHTRW5ITVJ?
CAL-54M2n0VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXqT25rUUN3ME2xMlA{QTV7IN88US=>MUjTRW5ITVJ?
DU-145NUfqfI5DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3fqfWlEPTB;MT6wPFA4OyEQvF2=NHq2cpVUSU6JRWK=
HCE-4MnKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33kNGlEPTB;MT6wPVI5PiEQvF2=Mom3V2FPT0WU
U-266MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7VTWM2OD1zLkC5OlM{KM7:TR?=M1;EdXNCVkeHUh?=
HT-1197NFG3[FRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDYUpdzUUN3ME2xMlEyPDN6IN88US=>NHu3bGlUSU6JRWK=
EW-1NIW5TnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnnDTWM2OD1zLkG0NVI5KM7:TR?=M4PV[HNCVkeHUh?=
MHH-NB-11Ml3nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVrJR|UxRTFwMUWzOlgh|ryPMn;rV2FPT0WU
NCI-H2405M{XjUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoO1TWM2OD1zLkG2NVYh|ryPMkK1V2FPT0WU
COLO-668MnHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoKxTWM2OD1zLkG2OFkh|ryPNXjPVWZQW0GQR1XS
IMR-5NWS4VZhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLnPGtpUUN3ME2xMlE3QTN4IN88US=>NGnwXnZUSU6JRWK=
ARH-77MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLQNVFnUUN3ME2xMlIzQTJ2IN88US=>NEnwVY9USU6JRWK=
BHT-101M4X1NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MULJR|UxRTFwMkO0PUDPxE1?NXGwUpVqW0GQR1XS
SCC-25M1fq[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoezTWM2OD1zLkKzOVM3KM7:TR?=NIf5U|VUSU6JRWK=
NTERA-S-cl-D1M{LC[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\ITWM2OD1zLkK0N|Q3KM7:TR?=NHy5bXRUSU6JRWK=
MKN28M1nvZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnfiTWM2OD1zLkK1OlM3KM7:TR?=M{f5N3NCVkeHUh?=
KS-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTFwMkiyOlkh|ryPNG\vNHFUSU6JRWK=
NCI-H1734NI\YXGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTFwMki5NVMh|ryPMoT3V2FPT0WU
ES7Mof3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XkSGlEPTB;MT6yPVU1OiEQvF2=NEezZ45USU6JRWK=
NCI-H838MlfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVrJR|UxRTFwM{C2NVUh|ryPMXXTRW5ITVJ?
HEC-1MkP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vvfWlEPTB;MT6zN|c2PSEQvF2=M1\YdXNCVkeHUh?=
ME-180NIjJZVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXi[ZEzUUN3ME2xMlM4QTl|IN88US=>Mk\hV2FPT0WU
MMAC-SFMlLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXhW3lyUUN3ME2xMlM6PTl3IN88US=>M4X5eXNCVkeHUh?=
IA-LMNUjjb2xJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nZVmlEPTB;MT60NFkyPCEQvF2=MYnTRW5ITVJ?
MN-60MoHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTFwNEOxNVQh|ryPMoDQV2FPT0WU
SIMANF3xXVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmLoTWM2OD1zLkS4Olg4KM7:TR?=MUTTRW5ITVJ?
NCI-H1770NITKcItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoXjTWM2OD1zLkWyNFU1KM7:TR?=MmH2V2FPT0WU
ONS-76M2HofGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1e2cGlEPTB;MT61NlMyOSEQvF2=M{[2cXNCVkeHUh?=
LB771-HNCM3z2U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NET5ZW9KSzVyPUGuOVM6ODZizszNM1yyR3NCVkeHUh?=
SW48M13ucWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYS3V|lbUUN3ME2xMlU1OjR|IN88US=>NFjucFVUSU6JRWK=
KYSE-140NEThXXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkX0TWM2OD1zLkW1O|QyKM7:TR?=NFjqSJRUSU6JRWK=
SW626MkfaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnqwTWM2OD1zLkW4NVYh|ryPMmnTV2FPT0WU
MC-CARMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEDpNZdKSzVyPUGuOVg3PjNizszNNULpd5ROW0GQR1XS
D-336MGMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTFwNkK5OEDPxE1?MVPTRW5ITVJ?
SK-MEL-3M3LIUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXlOVdKSzVyPUGuOlM6ODJizszNMVzTRW5ITVJ?
MHH-PREB-1MmDSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYHIVoZNUUN3ME2xMlY1PDd|IN88US=>M12y[3NCVkeHUh?=
Calu-1Mn\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnf3TWM2OD1zLk[1N|g3KM7:TR?=NVuzV2dlW0GQR1XS
HCC1806M1y0Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGWxc5BKSzVyPUGuOlY3OTFizszNM1;XS3NCVkeHUh?=
A101DMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofBTWM2OD1zLk[2O|gyKM7:TR?=NVXMbJBvW0GQR1XS
A704NVjkXGdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1nnOGlEPTB;MT62PFMyOSEQvF2=MXrTRW5ITVJ?
LB831-BLCNU\3NpFbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\We2lEPTB;MT62PVg2PCEQvF2=M17RSXNCVkeHUh?=
RL95-2NYH6OVBPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW\aTGU5UUN3ME2xMlcyPDZ|IN88US=>MUHTRW5ITVJ?
RPMI-2650MlnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MonyTWM2OD1zLkeyO|E6KM7:TR?=MknHV2FPT0WU
NH-12MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkfFTWM2OD1zLkezOFI4KM7:TR?=M{LoOXNCVkeHUh?=
AGSM1jPe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NY[xNmh[UUN3ME2xMlc3OzV6IN88US=>NYj1U5A4W0GQR1XS
NEC8M2XHRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHYTWM2OD1zLke4PVk2KM7:TR?=MV;TRW5ITVJ?
NCI-H2009NWTLWmlrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF\iNYlKSzVyPUGuO|k4OjFizszNNVjQb4ZFW0GQR1XS
A498MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvEXYpXUUN3ME2xMlgyOjh{IN88US=>M4\TT3NCVkeHUh?=
NCI-H810NFHqNFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M131O2lEPTB;MT64NVYxPiEQvF2=MVjTRW5ITVJ?
SK-NEP-1NGLTdGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4PMZmlEPTB;MT64N|c3PyEQvF2=NEGxcoFUSU6JRWK=
D-542MGM1rnNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml21TWM2OD1zLki1PFUyKM7:TR?=NHP0PYNUSU6JRWK=
KNS-42MorMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHuTWM2OD1zLki2NlY3KM7:TR?=NF7aW|BUSU6JRWK=
NCI-H2452NIGzTnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULBbHhYUUN3ME2xMlg6ODd2IN88US=>Mn;xV2FPT0WU
SK-MEL-2NV3y[ZRIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTFwOUCyO|Eh|ryPNH3lZ5hUSU6JRWK=
OVCAR-5M33pUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIO4c4pKSzVyPUGuPVA3PzVizszNNGrYOY5USU6JRWK=
SNG-MNE\4eJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\GSmlEPTB;MT65OVg2QCEQvF2=MkXNV2FPT0WU
A673MlXtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH;CW2pKSzVyPUGuPVc2OTZizszNNGPDW3JUSU6JRWK=
L-428NHvTU4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTFwOUmxO|kh|ryPMUPTRW5ITVJ?
KM-H2NX\DcpN{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUe4b2NOUUN3ME2yMlAyODlizszNNYTlVJFIW0GQR1XS
MC-IXCNXS3dZAzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVfnVJltUUN3ME2yMlAzOjd|IN88US=>MlL4V2FPT0WU
COLO-678MnnDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\TR481UUN3ME2yMlA1OjB5IN88US=>NHywVpJUSU6JRWK=
MEL-JUSOMXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTJwMEe4OVEh|ryPMXLTRW5ITVJ?
HCC38MomyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTJwMEi0N|Mh|ryPNW\LfYR6W0GQR1XS
UACC-62NIrBTHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml75TWM2OD1{LkC4PFU2KM7:TR?=M1frPXNCVkeHUh?=
OAW-42MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUTBVmNpUUN3ME2yMlA6PzFzIN88US=>NVn6[GlHW0GQR1XS
LB996-RCCMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmrhTWM2OD1{LkGzPFE4KM7:TR?=NWHoeWRzW0GQR1XS
COR-L105Moe3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH;rcmxKSzVyPUKuNVY{PzNizszNNHi1[2JUSU6JRWK=
RCC10RGBNVTXOJZ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRTJwMUi1O|Yh|ryPNFLKOYJUSU6JRWK=
A431MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYLwfnFLUUN3ME2yMlE6ODF7IN88US=>NVzTVGpEW0GQR1XS
NCI-H292MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nI[WlEPTB;Mj6yN|k2OSEQvF2=MlvaV2FPT0WU
SK-UT-1MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWHJR|UxRTJwM{OxPFQh|ryPNELaTlNUSU6JRWK=
PANC-08-13NGnVb5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTJwM{OyN|Uh|ryPNWrHb25zW0GQR1XS
ST486M13zVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXTTWM2OD1{LkSxNFQ5KM7:TR?=NYjGSnhDW0GQR1XS
SJSA-1NGfTbIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEHmd5VKSzVyPUKuOFEzPzFizszNNF34TFlUSU6JRWK=
RKOMljwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LVcGlEPTB;Mj60NlAzQSEQvF2=NULQbnBzW0GQR1XS
NCI-H1793Ml;1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVra[|lqUUN3ME2yMlQ1ODJ7IN88US=>MWTTRW5ITVJ?
639-VM3r2TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTJwNEWzPFIh|ryPMoHKV2FPT0WU
ES3NWfl[XNtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTJwNEm3N|ch|ryPMlPGV2FPT0WU
NCI-H1792M3\iU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHyfGVKSzVyPUKuOVY5OjZizszNMVnTRW5ITVJ?
NCI-H1651M2LHNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHmwUZpKSzVyPUKuOVgzOSEQvF2=NEX2SmtUSU6JRWK=
SN12CM4LkWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTJwNUi0PFch|ryPMn\vV2FPT0WU
COLO-679M2D2XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTJwNUi2NFUh|ryPNF3TV3ZUSU6JRWK=
U-118-MGNUHuVpRGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTJwNUi4O|Ih|ryPMXTTRW5ITVJ?
Ramos-2G6-4C10MoX0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\UdGlEPTB;Mj62OFgxPyEQvF2=MmHPV2FPT0WU
HCT-15MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkX5TWM2OD1{Lk[4O|kzKM7:TR?=M1K4enNCVkeHUh?=
MDA-MB-157Mln0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml32TWM2OD1{LkewO|Q4KM7:TR?=MUXTRW5ITVJ?
K5NEHENo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfwN2pKSzVyPUKuO|E5PDVizszNNFvDWo9USU6JRWK=
MKN45MmnzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIf0cFNKSzVyPUKuO|M{PjZizszNMXjTRW5ITVJ?
DMS-273NF;WdXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHzqPXZKSzVyPUKuO|U3OzJizszNMorqV2FPT0WU
C8166MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFvzcJNKSzVyPUKuO|g2OTNizszNNUX2bFhWW0GQR1XS
Calu-3NW\aPYdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEPWeGNKSzVyPUKuO|g6PjlizszNMmnoV2FPT0WU
SNB75Ml62S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTJwOEi1N|Uh|ryPNFfmc3NUSU6JRWK=
BFTC-905Ml;lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTJwOUCxPVEh|ryPNHvqOJlUSU6JRWK=
C-4-IIM{\sWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4jHSGlEPTB;Mj65NVM2OyEQvF2=M1HlUnNCVkeHUh?=
MS-1NFfmU5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEnRRnZKSzVyPUKuPVY4PjlizszNMnXEV2FPT0WU
A375MnTFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPIZ|RqUUN3ME2zMlA5OTh2IN88US=>NYTwNlF2W0GQR1XS
KYSE-70MlrLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHoTmxKSzVyPUOuNFg5QDJizszNNYO5ZWpEW0GQR1XS
KYSE-510MlLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3lfmpsUUN3ME2zMlExQTl3IN88US=>NEexV3JUSU6JRWK=
LN-405M135PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4jPPGlEPTB;Mz6xN|UyQCEQvF2=NEXLNJBUSU6JRWK=
BOKUMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlrZTWM2OD1|LkG0NlU3KM7:TR?=NXHQ[ldsW0GQR1XS
TE-10NYrkRZp7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkjDTWM2OD1|LkG3N|YzKM7:TR?=MmLYV2FPT0WU
MKN1Ml;PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4G3ZWlEPTB;Mz6xPFQ5OyEQvF2=M4P0PHNCVkeHUh?=
M059JMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV:3XXhYUUN3ME2zMlIxOTd|IN88US=>MVnTRW5ITVJ?
GOTONHzmcotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTNwMkKwN|kh|ryPNWjMc5J6W0GQR1XS
DK-MGNVi5WnNpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M120dGlEPTB;Mz6yOVk4PiEQvF2=M{ey[HNCVkeHUh?=
NCI-H727M{\MN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnHTWM2OD1|LkK2OVgh|ryPNHSzdlNUSU6JRWK=
NB12MmnXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUK3T3FbUUN3ME2zMlM{OjJ2IN88US=>M4f3THNCVkeHUh?=
DOKNVrNepNIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXKfmFKSzVyPUOuN|YyQDZizszNNWDCSpk4W0GQR1XS
KYSE-410M{PvNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIjE[VdKSzVyPUOuN|YzQDdizszNNXz6e41YW0GQR1XS
AM-38M135NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTNwM{iwOVEh|ryPNXvofmt2W0GQR1XS
GR-STM1\vUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnxN2dKSzVyPUOuOFU4OzJizszNNGj3TmZUSU6JRWK=
D-247MGNEjFcXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTNwNEiyOlMh|ryPMVjTRW5ITVJ?
TE-8M37YVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3f1T2lEPTB;Mz60PVM{OyEQvF2=NH;CfGJUSU6JRWK=
LS-411NM{f0NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1S4VmlEPTB;Mz60PVY6OiEQvF2=M{HVXHNCVkeHUh?=
SK-MES-1MkfGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XwUmlEPTB;Mz61OlQ{OyEQvF2=NEXj[IpUSU6JRWK=
SF295NGDrNVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NG\p[XZKSzVyPUOuOlE2PTJizszNNFnHfG1USU6JRWK=
SK-MEL-30MlXrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mmr5TWM2OD1|Lk[1PVIyKM7:TR?=M1\QUHNCVkeHUh?=
LB2241-RCCNV\3XolQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MniyTWM2OD1|Lk[2NlYh|ryPMlWyV2FPT0WU
PC-14M1GyTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\tTWM2OD1|Lk[2OFM4KM7:TR?=M2GzUnNCVkeHUh?=
EW-7MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlqzTWM2OD1|Lk[3Olk{KM7:TR?=MVvTRW5ITVJ?
NMC-G1NEHhb4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfjUFdpUUN3ME2zMlcyQDN5IN88US=>MkfjV2FPT0WU
TE-441-TMmfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF2wSZFKSzVyPUOuO|MxOjhizszNMkXIV2FPT0WU
NCI-H1618MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTNwOEG4O|Uh|ryPNGjxSJNUSU6JRWK=
PANC-03-27M{HS[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1HCbmlEPTB;Mz64NVkyPiEQvF2=MkfXV2FPT0WU
NCI-H2228M2PHVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGX5ZnZKSzVyPUOuPFMyOjZizszNMl20V2FPT0WU
CAPAN-1MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTNwOEewNFkh|ryPM17TbXNCVkeHUh?=
KLEM4S4c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;TTWM2OD1|LkmwOlch|ryPNVj6VXp3W0GQR1XS
BeckerNWPQNnFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\4[mU2UUN3ME2zMlkzQDR7IN88US=>MU\TRW5ITVJ?
SK-PN-DWM4\Rdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2jJbWlEPTB;ND6wO|k4PCEQvF2=NInMXmtUSU6JRWK=
Hs-578-TMnnIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXLJR|UxRTRwMEizNFYh|ryPM1HERXNCVkeHUh?=
RS4-11M3TSS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1Ti[GlEPTB;ND6xNVI2PSEQvF2=M2TQ[3NCVkeHUh?=
D-502MGM2\QTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2L1bGlEPTB;ND6xOlk6PyEQvF2=MVjTRW5ITVJ?
GI-1NIrwbnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXJTWM2OD12LkK4Nlk6KM7:TR?=NVyyNVFbW0GQR1XS
NCI-H209NV22dW5uT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3X6[mlEPTB;ND6zN|c5KM7:TR?=MVXTRW5ITVJ?
SK-OV-3NHfCWWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zGb2lEPTB;ND60PFE1QSEQvF2=NEjuOWpUSU6JRWK=
LOUCYNXW2OoV{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{HWVGlEPTB;ND60PFQ{OiEQvF2=MYXTRW5ITVJ?
NCI-H69MkjzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHrTWM2OD12LkWxO|k{KM7:TR?=M3LsOHNCVkeHUh?=
SCC-9MkPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTUTWM2OD12LkWzNVczKM7:TR?=MWjTRW5ITVJ?
NCI-H526MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHfVUWZKSzVyPUSuOVkzQTNizszNMXLTRW5ITVJ?
NCI-H2170MkjHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnQTWM2OD12Lk[2O|cyKM7:TR?=M3vmfnNCVkeHUh?=
SRMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofmTWM2OD12LkewNFQ5KM7:TR?=NHTVbmVUSU6JRWK=
CMKNVrBWpBpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTRwN{KxNFEh|ryPMVTTRW5ITVJ?
COLO-829MmW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTRwN{ewOFMh|ryPMWrTRW5ITVJ?
HuO-3N1NH;a[4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUXJR|UxRTRwOEOyPFEh|ryPMmO4V2FPT0WU
5637NX\4PIx3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLGTWM2OD12LkmwOFg4KM7:TR?=NGjpUXRUSU6JRWK=
A253MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHHBfY5KSzVyPUSuPVc4ODhizszNM3PY[nNCVkeHUh?=
NB10MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1LNS2lEPTB;NT6wO|Q6PyEQvF2=MnrXV2FPT0WU
SF539MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NW\DOlRnUUN3ME21MlA6QTV7IN88US=>MlXJV2FPT0WU
HAL-01MojVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4jHN2lEPTB;NT6xOFY1PSEQvF2=MXzTRW5ITVJ?
MHH-ES-1NVrMPFR[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnnaTWM2OD13LkG2PVI2KM7:TR?=NFmwOpFUSU6JRWK=
DELNHrC[JFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTVwMke1PFIh|ryPMYTTRW5ITVJ?
NCI-H1299MoTiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVjGW4lrUUN3ME21MlM2ODB5IN88US=>M3LEcnNCVkeHUh?=
ChaGo-K-1NYOxZWt3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTsWJFyUUN3ME21MlM2OTB5IN88US=>NGPhXWtUSU6JRWK=
HMV-IIMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIrRV41KSzVyPUWuN|k1OyEQvF2=M1XwVXNCVkeHUh?=
NB69NVPqR|JxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mni0TWM2OD13LkO5OlMyKM7:TR?=NHm4[GdUSU6JRWK=
NCI-H1882NGC4eFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HvWmlEPTB;NT60N|M3PCEQvF2=M{\tTHNCVkeHUh?=
SNU-475M2H3WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nveWlEPTB;NT60O|E4OSEQvF2=NHnFTYFUSU6JRWK=
RXF393M4TUdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnGPYpZUUN3ME21MlQ5PDl2IN88US=>NEjyTXRUSU6JRWK=
CAL-51NXrBb41LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXXqW3pGUUN3ME21MlYzQDV|IN88US=>NWT1dWpjW0GQR1XS
SW1573MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zDfGlEPTB;NT62N|U{PCEQvF2=MXPTRW5ITVJ?
GCTNILlUWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnH5TWM2OD13Lke1PVI6KM7:TR?=Mk\SV2FPT0WU
COR-L88MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mo[2TWM2OD13Lke2PFQ3KM7:TR?=NHT2[ldUSU6JRWK=
MDA-MB-134-VIMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTWTWM2OD13Lki3OVM3KM7:TR?=MVHTRW5ITVJ?
NB5M1vqU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnXWnNKSzVyPUWuPVI1PCEQvF2=MnznV2FPT0WU
GMS-10MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\FTWM2OD13Lkm2PFYyKM7:TR?=MmHMV2FPT0WU
CHP-212MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEfzeGpKSzVyPU[uOFgzPjdizszNM{Hib3NCVkeHUh?=
TE-11MlvQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHwTWM2OD14LkW1NVgzKM7:TR?=MmPuV2FPT0WU
SW962M165Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYrVe|VEUUN3ME22MlY2Pzd2IN88US=>MWPTRW5ITVJ?
MZ2-MELNVvpfIs1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTz[odHUUN3ME22MlgzODFzIN88US=>MXHTRW5ITVJ?
C-33-ANIrjR21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXv0[ZE4UUN3ME22MlkyPjh6IN88US=>NVvEVVV7W0GQR1XS
IGR-1NEfKOpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1PKemlEPTB;Nj65O|gzPiEQvF2=MXXTRW5ITVJ?
MOLT-4NV7Z[2dTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4L3SGlEPTB;Nz6xOVQxPiEQvF2=MW\TRW5ITVJ?
NCI-H1650NIDrd2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfMTWM2OD15LkK3NFQ3KM7:TR?=NFP5bGNUSU6JRWK=
AsPC-1NGDrfZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTdwMki2NFUh|ryPNF\PdJVUSU6JRWK=
SNU-C2BM3vDPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFLjU3FKSzVyPUeuNlk2PzFizszNMVrTRW5ITVJ?
MKN7M4r6Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnjZTWM2OD15LkO3NlM2KM7:TR?=MUfTRW5ITVJ?
SW620Ml3RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEjPXHRKSzVyPUeuN|gzODVizszNMl3kV2FPT0WU
SK-MEL-28MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTdwNEC3PVgh|ryPM1fWOHNCVkeHUh?=
TE-6NV76OGpsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWO4NoZmUUN3ME23MlQ1QTB6IN88US=>M{nse3NCVkeHUh?=
D-263MGNXPTeWZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUPJR|UxRTdwNEW3OlIh|ryPNYH0cmFjW0GQR1XS
NCI-H1355NIDNenFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTPTWM2OD15Lke3NFI6KM7:TR?=NWfCNFhzW0GQR1XS
DSH1NH3D[WJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1yye2lEPTB;Nz63PVc3OiEQvF2=NGO3eWpUSU6JRWK=
NCI-H460NXXNcYdJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYDJR|UxRThwMEC2PVQh|ryPNGDm[IRUSU6JRWK=
NCI-H1563NVHJNmhHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\WTmxkUUN3ME24MlA4PTB6IN88US=>NV7WSHBMW0GQR1XS
SW948M4XBSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFWyeFVKSzVyPUiuNVA4PDRizszNM1fEUXNCVkeHUh?=
LK-2M4DzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRThwMUK4N|Mh|ryPMn[3V2FPT0WU
HT-1080MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUPJR|UxRThwMUOxO|Uh|ryPNUDCSGY1W0GQR1XS
NCI-H441NFe4NYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUToV4NPUUN3ME24MlE6OyEQvF2=M1H4SnNCVkeHUh?=
HSC-4NYf1dFlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml3pTWM2OD16LkK4O|Ih|ryPNV2xPW5oW0GQR1XS
LXF-289M{T3W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zibGlEPTB;OD6zOVk1OyEQvF2=MlvmV2FPT0WU
MRK-nu-1NXTO[nlxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1yyWGlEPTB;OD6zOlMxPCEQvF2=MmG1V2FPT0WU
no-11MnLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFOzO3JKSzVyPUiuOFcyOzNizszNMVnTRW5ITVJ?
SNU-387M4TqXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFvpN4RKSzVyPUiuOlMzPDZizszNNXG2dlVrW0GQR1XS
Detroit562NFfDW3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHO1dYlKSzVyPUiuO|U1PTVizszNNGXDbYdUSU6JRWK=
SW954M1e0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRThwN{[4N|Ih|ryPNXn5SYpSW0GQR1XS
P12-ICHIKAWAM2XVPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPGTWM2OD16Lke4PVQh|ryPNEXmVlVUSU6JRWK=
TE-9NUi4NFNpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXTJR|UxRThwOEGwOlIh|ryPM{fWOHNCVkeHUh?=
NB13MkLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn\2TWM2OD16LkizO|k3KM7:TR?=MkDJV2FPT0WU
BPH-1NFjxbHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7YRXZKSzVyPUiuPFUxQDFizszNNHTLPXpUSU6JRWK=
KMOE-2M37JVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1TmS2lEPTB;OD64O|g6OiEQvF2=NGe3To9USU6JRWK=
RPMI-8402MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvKfos6UUN3ME24Mlg6QTJ4IN88US=>NGK5NI1USU6JRWK=
OVCAR-3NH2ySmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTNbYNnUUN3ME24Mlk4PzN{IN88US=>NH;uOHdUSU6JRWK=
NCI-H2196NFrCN3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRThwOUi2NFYh|ryPM{nSW3NCVkeHUh?=
MZ7-melNWXYXlVLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\ldmlEPTB;OT6wN|Q3KM7:TR?=NXvqfGxMW0GQR1XS
GP5dMoK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlH0TWM2OD17LkC2N|E{KM7:TR?=M1TXTnNCVkeHUh?=
NCI-N87M4\wT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DZcGlEPTB;OT60OFc{OSEQvF2=MVjTRW5ITVJ?
EW-16Mn2wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHqTWM2OD17LkS0PFQ5KM7:TR?=NVy1NZh3W0GQR1XS
Calu-6NX\JRm5pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlG2TWM2OD17LkS5O|A{KM7:TR?=MXTTRW5ITVJ?
LC4-1NYixbHJVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTlwNkK1O{DPxE1?NHri[YFUSU6JRWK=
CCRF-CEMNGC0N5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnThTWM2OD17Lk[4O|Y3KM7:TR?=MVfTRW5ITVJ?
BC-1M{Hjcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4TzcGlEPTB;OT63PFk6KM7:TR?=NIjEVI9USU6JRWK=
NCI-SNU-16NIfONGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTlwN{m0PVUh|ryPMmnUV2FPT0WU
NCI-H28MmHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{fFT2lEPTB;OT64OFk{OyEQvF2=NH\uSWhUSU6JRWK=
SBC-1MkLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknuTWM2OD1zMD6wO|Ih|ryPNE\ad4xUSU6JRWK=
TURNFi2RWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTOfnJHUUN3ME2xNE4yPjV5IN88US=>MWXTRW5ITVJ?
MDA-MB-231NUDMRZoxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTFyLkKxNVQh|ryPMX3TRW5ITVJ?
C3ANUf6Oo94T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF:4TpdKSzVyPUGwMlMyPzlizszNMoHqV2FPT0WU
SW1990MnH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTFyLkOyPEDPxE1?M3\5OXNCVkeHUh?=
NCI-H1993NH72XWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTFyLkW2PVMh|ryPMlPNV2FPT0WU
SK-CO-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYOySINSUUN3ME2xNE44PzdizszNM3;UNXNCVkeHUh?=
OAW-28MkfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTFyLkm4PFgh|ryPMmP2V2FPT0WU
HNNIXmRmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTFzLkGxN|Eh|ryPMWPTRW5ITVJ?
NCI-H1304MmnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTFzLkG1O|Yh|ryPM2PGUnNCVkeHUh?=
DaoyMoC3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFL5e|FKSzVyPUGxMlQ{OzZizszNMWLTRW5ITVJ?
VA-ES-BJMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF21bpJKSzVyPUGxMlcyQTVizszNNYfL[pA1W0GQR1XS
MCF7M3\4OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTqNINKSzVyPUGxMlgyOjZizszNMlXDV2FPT0WU
VM-CUB-1NXXyVJliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPrfXdSUUN3ME2xNU46ODlzIN88US=>NXrlPZhOW0GQR1XS
IPC-298MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvHXW5ZUUN3ME2xNU46Ozh|IN88US=>MkmwV2FPT0WU
NCI-H2126NV[weopYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTuZlEzUUN3ME2xNk4xOjF6IN88US=>MoTTV2FPT0WU
OVCAR-8NETaSWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPvTWM2OD1zMj6xNVQyKM7:TR?=NX;qVYhsW0GQR1XS
SJRH30MofIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTF{LkKyPVkh|ryPMYDTRW5ITVJ?
DMS-53MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUj0SHZJUUN3ME2xNk4zPjR7IN88US=>M1:2dnNCVkeHUh?=
NCI-H322MM4fVSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYH5PZVXUUN3ME2xNk4{OzV5IN88US=>NFPzW4tUSU6JRWK=
RVH-421MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfnTWM2OD1zMj60PVA1KM7:TR?=NHzGbGJUSU6JRWK=
RajiNEOwU2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH;JUFRKSzVyPUGyMlYyPCEQvF2=MX7TRW5ITVJ?
MDA-MB-415NW\Hb4h7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTF{Lk[0OFQh|ryPMWnTRW5ITVJ?
EFE-184MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NInwWIhKSzVyPUGyMlcyODZizszNMoSxV2FPT0WU
BFTC-909M{jUW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIPRVoxKSzVyPUGyMlkzPDdizszNNFOz[5lUSU6JRWK=
BHYNI\YN41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{THWGlEPTB;MUOuN|M6KM7:TR?=NFjBOFBUSU6JRWK=
YKG-1MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTF|LkO3OFkh|ryPNH76bXRUSU6JRWK=
EW-3NEHsdpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTF|LkexOlMh|ryPMWPTRW5ITVJ?
HCC1143NIXOdmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PPVGlEPTB;MUOuO|Q{PyEQvF2=NWniSoR1W0GQR1XS
REHNWLs[XluT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTF|Lki5PFIh|ryPMnLRV2FPT0WU
CESSMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1PkOGlEPTB;MUOuPVQ5QSEQvF2=MVLTRW5ITVJ?
EFM-19MmfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3Hl[GlEPTB;MUSuNVEyOiEQvF2=Ml\4V2FPT0WU
U031M2LSTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfTS|VnUUN3ME2xOE41ODh3IN88US=>M2T4THNCVkeHUh?=
ES1MkPQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NULKTWZYUUN3ME2xOE41QDVzIN88US=>MlXrV2FPT0WU
HSC-3NEixOXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVvpeoxuUUN3ME2xOE43OjF3IN88US=>NXqzbXRDW0GQR1XS
LOXIMVIM2m3dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTF2LkewOlgh|ryPM2DuN3NCVkeHUh?=
A388M3jyVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTF2Lke1OVYh|ryPMYLTRW5ITVJ?
KP-N-YSM3vvfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTuV29KSzVyPUG0Mlc4OyEQvF2=MkT1V2FPT0WU
Capan-2M{nSN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFf0OmdKSzVyPUG0Mlc5PiEQvF2=NE\sV2FUSU6JRWK=
SKG-IIIaNWLBZ45CT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTF2Lki4OlIh|ryPNX72SXlyW0GQR1XS
HELMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;ITWM2OD1zND64PVk4KM7:TR?=NFrGbGFUSU6JRWK=
BENNGW0N4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTF2Lkm3OlYh|ryPNY\LbnpKW0GQR1XS
MC116M2PSfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXw[WVKSzVyPUG1MlE2QTlizszNMVHTRW5ITVJ?
IGROV-1MnHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfRTWM2OD1zNT6yN|E4KM7:TR?=NYrteVdQW0GQR1XS
NCI-H1648M2OzfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrlPYFKSzVyPUG1MlU{ODVizszNMn\nV2FPT0WU
ABC-1M1XrbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTF3LkiwN|Mh|ryPNGG4bZdUSU6JRWK=
EW-18NXLvR5JGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHlTWM2OD1zNT65PVc6KM7:TR?=NHzHUphUSU6JRWK=
BC-3M1rMb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\CTWM2OD1zNj6wOVYzKM7:TR?=MYnTRW5ITVJ?
NCI-H1437NETzdmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYroZldPUUN3ME2xOk4xPjZ5IN88US=>MXnTRW5ITVJ?
SCC-15NV3jO5V[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PSRmlEPTB;MU[uNlgzPSEQvF2=MU\TRW5ITVJ?
TTNVzlUId3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWDJR|UxRTF4LkW4PFgh|ryPNHrDXJpUSU6JRWK=
KINGS-1MnvFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGLseXRKSzVyPUG2MlgzPzNizszNNHLQblVUSU6JRWK=
C32NUnyXFlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPRXlJLUUN3ME2xOk46PzF5IN88US=>NWHOZ4ZYW0GQR1XS
SBC-5NHz6d4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTF5LkG0O|kh|ryPMXXTRW5ITVJ?
NB1MkLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MY\JR|UxRTF5LkOxPFgh|ryPMW\TRW5ITVJ?
EB-3MnLhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3f4emlEPTB;MUeuOVc3KM7:TR?=MoPRV2FPT0WU
NCI-H748NX7LOHdmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\oTWM2OD1zNz63NFM2KM7:TR?=MlHZV2FPT0WU
IST-SL1MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXr6VG81UUN3ME2xO{44PTJ4IN88US=>NIX2SlBUSU6JRWK=
WM-115M{P3cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIDFUoxKSzVyPUG3MlgxQDVizszNM3rCZnNCVkeHUh?=
NCI-H226NYrVcZpGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTF5Lkm1OFYh|ryPNGjoN5dUSU6JRWK=
CAL-33M3HPTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGfKNVBKSzVyPUG4MlI4QDFizszNNFHiS5FUSU6JRWK=
SCC-4MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVvJR|UxRTF6LkOyNlkh|ryPMoPYV2FPT0WU
RMG-IM1\3W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTF6Lk[5OFch|ryPMlPTV2FPT0WU
KOSC-2M3\s[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUS2[Zp5UUN3ME2xPE44PzR4IN88US=>NYTXS4p5W0GQR1XS
A2058M17CN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nnfWlEPTB;MUiuPFI2PSEQvF2=NEPP[2lUSU6JRWK=
HCC70Mm\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPSTWM2OD1zOT6zPFk1KM7:TR?=NWTJ[IVbW0GQR1XS
C2BBe1M1ToNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHjNW9MUUN3ME2xPU41OTR6IN88US=>M2Hk[3NCVkeHUh?=
NCI-H650NVzuWoJqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mle2TWM2OD1zOT61PFk6KM7:TR?=M1fqenNCVkeHUh?=
CAL-72NHnseYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFy3Z5RKSzVyPUG5MlY4OzdizszNMUTTRW5ITVJ?
L-363M4XjcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfXT4E5UUN3ME2yNE4xOjF{IN88US=>MX7TRW5ITVJ?
SNU-423MkXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3Ue2tOUUN3ME2yNE4yODR|IN88US=>MXPTRW5ITVJ?
PLC-PRF-5M3vUSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\NTWM2OD1{MD6zPVA3KM7:TR?=NYLkdJg3W0GQR1XS
SW1463MkjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXmVphKSzVyPUKwMlQ2OjVizszNNGnJV2hUSU6JRWK=
769-PNFjSSlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jXbGlEPTB;MkCuOlc3QSEQvF2=NVK2fFdDW0GQR1XS
DMS-79M1;ScWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHX3R2lKSzVyPUKwMlg1QSEQvF2=MUfTRW5ITVJ?
Saos-2NUmyZmgyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2T2SWlEPTB;MkCuPVU2PiEQvF2=MUHTRW5ITVJ?
CHP-126Ml;NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4rTU2lEPTB;MkGuOFQ3OiEQvF2=MX7TRW5ITVJ?
SW837MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTJzLkS5N|kh|ryPM1:z[XNCVkeHUh?=
SHP-77NGjabmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmD0TWM2OD1{MT62NVIzKM7:TR?=MWXTRW5ITVJ?
DBNITsd2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYXJR|UxRTJzLk[xOFIh|ryPNFm5N2tUSU6JRWK=
ES5NWL6fmx5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;BS4tKSzVyPUKxMlY5PjRizszNMliwV2FPT0WU
COR-L23MlO3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTJzLkiwOVEh|ryPMkPmV2FPT0WU
KU-19-19MoDtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33q[GlEPTB;MkGuPFk5OiEQvF2=M1XH[HNCVkeHUh?=
T84NUPJToYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NECyUXhKSzVyPUKxMlk5OTlizszNM{LaRnNCVkeHUh?=
NCI-H630MlH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTJ{LkWzOlMh|ryPNIq1Z3lUSU6JRWK=
LU-165Moj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTFTWM2OD1{Mj61OVQh|ryPM1zOcXNCVkeHUh?=
COLO-792NVS4NZl1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXq3UZppUUN3ME2yNk44OTFzIN88US=>NIfnV|NUSU6JRWK=
CAL-62NELCbHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTJ{Lke1NVch|ryPNEXyUmNUSU6JRWK=
HCE-TNIDXTlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTJ{Lki2NFYh|ryPMX;TRW5ITVJ?
BB65-RCCM3PBcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX\xT3RUUUN3ME2yN{4xOzR2IN88US=>NWPnRWtTW0GQR1XS
SiHaNVTZW5FYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTJ|LkO5Olgh|ryPMYrTRW5ITVJ?
NCI-H2081NIHC[G5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjFTWM2OD1{ND6wOlQyKM7:TR?=NI\MWoVUSU6JRWK=
U251M1[xXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVK0OpN5UUN3ME2yOE4xPjZ6IN88US=>MXfTRW5ITVJ?
LoVoM{nDNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIjJVlJKSzVyPUK0MlkzQDJizszNMXHTRW5ITVJ?
GCIYMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fzcGlEPTB;MkWuNlg4PyEQvF2=NGPadWdUSU6JRWK=
NUGC-3NIrad45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoTkTWM2OD1{NT6zN|E3KM7:TR?=NF[zcmhUSU6JRWK=
LNCaP-Clone-FGCM2T5Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonjTWM2OD1{NT6zOFk5KM7:TR?=NFnhZnZUSU6JRWK=
PA-1NVn2O4ZrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIr2[HlKSzVyPUK1MlY5OzNizszNMU\TRW5ITVJ?
OE33Mo\PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjJTnFKSzVyPUK1MlY5PTNizszNNHT6OYhUSU6JRWK=
HT-29MknFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jySmlEPTB;MkWuO|g4QSEQvF2=M4q3fHNCVkeHUh?=
RCM-1NYHaS5J7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTJ3Lkm2OVYh|ryPNHvZ[YRUSU6JRWK=
NCI-H1522MknDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVK1eY9TUUN3ME2yOU46QTFzIN88US=>NF7IVGpUSU6JRWK=
LB373-MEL-DMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTuZ3dOUUN3ME2yOk4yPzB6IN88US=>MYLTRW5ITVJ?
NCI-H1436M1foeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIn1OnRKSzVyPUK2MlI4OzhizszNNIT2OmJUSU6JRWK=
COLO-824M3X0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTJ4LkSwNFIh|ryPNIPsfGlUSU6JRWK=
CP50-MEL-BNGPMTndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnyyTWM2OD1{Nj61Olc2KM7:TR?=MX\TRW5ITVJ?
EGI-1NFzqWpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPzU|RKSzVyPUK3MlI3QThizszNMVvTRW5ITVJ?
LAN-6NWjVSpp7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\hWGZkUUN3ME2yO{4{PTl6IN88US=>MmPUV2FPT0WU
GAKMnjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rkcWlEPTB;MkeuOFIzPSEQvF2=M1fpVHNCVkeHUh?=
MDA-MB-175-VIINFzpdYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnzmTWM2OD1{Nz61NFU{KM7:TR?=NFPWNZNUSU6JRWK=
JVM-2NUTVTmI1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1O4TGlEPTB;MkeuOlYzOiEQvF2=M1y2c3NCVkeHUh?=
UACC-257NEjsR3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3ezSWlEPTB;MkeuOlg4QCEQvF2=M3nLenNCVkeHUh?=
SW1783M2j4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mne4TWM2OD1{Nz63O|g{KM7:TR?=MlO3V2FPT0WU
HT-3MmOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXf1VoJqUUN3ME2yPE4zOTZ4IN88US=>NXn2NWpSW0GQR1XS
RLNXPYfpdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTJ6LkW5NVEh|ryPNHu2b2ZUSU6JRWK=
TK10M3PxN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\tTWM2OD1{OD62OVM2KM7:TR?=NXrq[I1EW0GQR1XS
HT55NEHiW3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vUNGlEPTB;MkmuNFU3PSEQvF2=M3jxSnNCVkeHUh?=
BT-20MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjRNnBUUUN3ME2yPU4xPTh4IN88US=>Ml\VV2FPT0WU
TGBC24TKBNITa[HFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXzJR|UxRTJ7LkG4N|Eh|ryPM17DR3NCVkeHUh?=
HSC-2MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTJ7LkOwNFEh|ryPMYfTRW5ITVJ?
COLO-205MlzRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnUTWM2OD1{OT6zPVQ1KM7:TR?=MV;TRW5ITVJ?
GT3TKBNGTUXlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn[wTWM2OD1{OT62PFc4KM7:TR?=NULmRYZUW0GQR1XS
T47DM{fyWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfodJVGUUN3ME2yPU45PTh{IN88US=>MV3TRW5ITVJ?
OMC-1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MULJR|UxRTNyLkG5NVkh|ryPMVPTRW5ITVJ?
PFSK-1Ml7TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFHXWnVKSzVyPUOxMlI3PTlizszNMlrWV2FPT0WU
JEG-3MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTNzLkO1OlEh|ryPMmPxV2FPT0WU
RDM1u0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\FTWM2OD1|MT61NVE2KM7:TR?=NUjpO5BtW0GQR1XS
NCI-H64NIfa[GdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmH4TWM2OD1|Mj60NVc6KM7:TR?=MV\TRW5ITVJ?
DMS-114M{XtNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHXhTpVKSzVyPUOyMlQyQDJizszNNHX4NZFUSU6JRWK=
NCI-H661Mn;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPhdYRoUUN3ME2zNk43PTBzIN88US=>M3TWenNCVkeHUh?=
CAL-148M2iwfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;NTWM2OD1|Mj62OlY2KM7:TR?=M3noW3NCVkeHUh?=
HuP-T3NYCzN5pHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\KbVJKSzVyPUOyMlk{OzhizszNM{K2NHNCVkeHUh?=
ES4NVrJT25jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{HFT2lEPTB;M{OuNVcxPSEQvF2=MVXTRW5ITVJ?
Ca9-22MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWLJR|UxRTN|LkS2NFEh|ryPMoLlV2FPT0WU
LP-1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYrmOXZvUUN3ME2zOE4xQSEQvF2=Ml;RV2FPT0WU
AU565NVHrWJhpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1n4VmlEPTB;M{SuOVA3QSEQvF2=NYjD[3VRW0GQR1XS
MDA-MB-453NFzaUZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkPQTWM2OD1|NT6xOFI3KM7:TR?=NXH3O|gxW0GQR1XS
SNU-C1NGXkVW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoXGTWM2OD1|NT6xO|Eh|ryPM{jiWnNCVkeHUh?=
SW13MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoriTWM2OD1|NT60NFc3KM7:TR?=MVXTRW5ITVJ?
NCI-H2122Moj2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnexTWM2OD1|NT61OVk5KM7:TR?=M1uzfXNCVkeHUh?=
NCI-H1395M{KwU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEj2[ZhKSzVyPUO1MlY3QTFizszNMo\JV2FPT0WU
J-RT3-T3-5NH61UIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MorLTWM2OD1|Nj6wNlk1KM7:TR?=MYPTRW5ITVJ?
COR-L279NEfQRmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnewTWM2OD1|Nj6xPVgyKM7:TR?=NW\E[XZNW0GQR1XS
ATN-1MkLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH\ZdYlKSzVyPUO2Mlg2OTZizszNM2nKUnNCVkeHUh?=
HCC2998M4\hVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTN4Lki1O|Eh|ryPM3\XN3NCVkeHUh?=
UM-UC-3NIq4TnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzIfm5KSzVyPUO2Mlg3PzVizszNMkjZV2FPT0WU
DV-90MnL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoTvTWM2OD1|Nj65NFY4KM7:TR?=MWrTRW5ITVJ?
ES8NYL5WpdKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVrWVohxUUN3ME2zOk46OzF6IN88US=>MXHTRW5ITVJ?
YAPCMkH3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnjKTWM2OD1|Nj65OlU1KM7:TR?=NUm2eHdoW0GQR1XS
HCC1599MoXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnX6TWM2OD1|Nz6xOlE5KM7:TR?=M4ricXNCVkeHUh?=
UMC-11MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PSSWlEPTB;M{euNlUxOyEQvF2=NW\6ZlBFW0GQR1XS
THP-1NIfvfVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYfDNnczUUN3ME2zO{4zQDZ6IN88US=>NWH3N4hLW0GQR1XS
OCUB-MNFzO[2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWfYdVdZUUN3ME2zO{4zQDlzIN88US=>MVjTRW5ITVJ?
NCI-H1693M2HvVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWrZbpNoUUN3ME2zO{4{OjN|IN88US=>Ml:xV2FPT0WU
NCI-H345NWPSRpZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3vFZmlEPTB;M{euN|YzPCEQvF2=Mlf1V2FPT0WU
COLO-800M3:3cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn70TWM2OD1|Nz61Olch|ryPNX7pem5uW0GQR1XS
COLO-320-HSRNGixfIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rUUGlEPTB;M{iuN|Q6OiEQvF2=NFnnbG5USU6JRWK=
NCI-H596MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjlXGpKSzVyPUO4MlQ1QDlizszNNV7xUmhuW0GQR1XS
NCI-H187MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{jOZ2lEPTB;M{iuO|M1PCEQvF2=Mo\kV2FPT0WU
ECC4MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF21V4xKSzVyPUO5MlA5OTRizszNM4DyRXNCVkeHUh?=
KP-4M160emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVX6fINkUUN3ME2zPU4yOjN3IN88US=>NE[0c3ZUSU6JRWK=
NCI-H2227NGjKeVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rMdGlEPTB;M{muN|k1QSEQvF2=M4q0N3NCVkeHUh?=
22RV1M4HxdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEW4SGVKSzVyPUO5Mlg{QThizszNMn:xV2FPT0WU
SASMmS2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;lUnpKSzVyPUSwMlA6PiEQvF2=NEGyTYxUSU6JRWK=
PANC-10-05NEXZRmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{mwN2lEPTB;NECuNVgzQCEQvF2=MVfTRW5ITVJ?
MDA-MB-468NILsbHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fIR2lEPTB;NECuOVM1PiEQvF2=MWDTRW5ITVJ?
RPMI-7951NEn5NYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTRzLkKwO|Uh|ryPNXfqcnhJW0GQR1XS
BB49-HNCNFXaT2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHheJBXUUN3ME20NU4zOTd7IN88US=>MW\TRW5ITVJ?
23132-87M3ywWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3XnTGlEPTB;NEGuNlc{OiEQvF2=Mo\YV2FPT0WU
HCC1569NX;2OJdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYDJR|UxRTRzLkK4PFUh|ryPNUHSNXBIW0GQR1XS
CP66-MELNWqzemFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\FNGlEPTB;NEKuNVg5PiEQvF2=MVHTRW5ITVJ?
K-562NWWz[5RYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTR{LkK4OVQh|ryPMU\TRW5ITVJ?
OCI-AML2NEfLfolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUi3d2dnUUN3ME20Nk45QTd2IN88US=>MUnTRW5ITVJ?
SW756M1\QR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTR|LkCzPFgh|ryPNUfpbFY3W0GQR1XS
M14M2P4Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTpd2dKSzVyPUSzMlMyQDlizszNMUjTRW5ITVJ?
NCI-H1623NUP6foFDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEm5WmVKSzVyPUSzMlQ3PCEQvF2=M1PvZnNCVkeHUh?=
KNS-81-FDNECzVHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlL1TWM2OD12Mz63OlIh|ryPMnryV2FPT0WU
TGBC1TKBNGjpO5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3mwUmlEPTB;NEOuPVA6QSEQvF2=MmnVV2FPT0WU
RERF-LC-MSMmn5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jLXGlEPTB;NEOuPVI5OSEQvF2=M1\1NnNCVkeHUh?=
PC-3MoT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHjTWM2OD12ND60N|Q4KM7:TR?=NIHZXGVUSU6JRWK=
HuP-T4NHrUSIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1;tcGlEPTB;NESuOFQ4PCEQvF2=MlHxV2FPT0WU
NCI-H510AMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlPjTWM2OD12ND63NFgh|ryPM4PkNHNCVkeHUh?=
LB2518-MELNX;mb2kzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDpTWM2OD12ND63PVM4KM7:TR?=NEXMU4RUSU6JRWK=
TE-5NYnvcoU{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWnCNJBXUUN3ME20OU46PThzIN88US=>M1zX[nNCVkeHUh?=
EW-24NXPvO|BuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4rKbGlEPTB;NE[uNVczOyEQvF2=MWLTRW5ITVJ?
LB647-SCLCNIfRU5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7icGRKSzVyPUS2MlIyPTVizszNNGXEWGxUSU6JRWK=
NCI-H524NGT0[mRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUfPfpBGUUN3ME20Ok44OTh3IN88US=>NHnvPZpUSU6JRWK=
EW-11MlW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYnOdGF4UUN3ME20Ok46Ozd|IN88US=>M{jtSXNCVkeHUh?=
KALS-1NGfWW2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1j6[mlEPTB;NEeuNlA3PiEQvF2=NX;0S3Y{W0GQR1XS
BT-474MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTR5LkSyNVYh|ryPMlm1V2FPT0WU
SK-N-ASNV\aemVRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17WdWlEPTB;NEeuPFg5KM7:TR?=NUjPeoNpW0GQR1XS
HCC2157MorwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXXQd5BOUUN3ME20PE4xPzZizszNMUnTRW5ITVJ?
HCC1954MlK3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2PDN2lEPTB;NEiuNVcxPCEQvF2=MXfTRW5ITVJ?
FADUMonsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXrJR|UxRTR6LkOwN|Eh|ryPMWrTRW5ITVJ?
S-117MkHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXtTWM2OD12OD6zPFE2KM7:TR?=MoXwV2FPT0WU
LS-1034MofsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnvxTWM2OD12OD63NFY4KM7:TR?=Mk[wV2FPT0WU
CAMA-1MlroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnN[ZVKSzVyPUS5MlU2PDNizszNNHzwdFNUSU6JRWK=
LU-134-AMlu1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\zWmFKSzVyPUS5MlgxQDVizszNMoGzV2FPT0WU
NCI-H1838NH36OHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXkTWM2OD12OT64NFg4KM7:TR?=MU\TRW5ITVJ?

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-01-10)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2
NCT02478164 Recruiting Glioblastoma Dana-Farber Cancer Institute July 2015 Phase 2
NCT02448095 Not yet recruiting Chronic Myeloid Leukemia|Philadelphia Positive Gruppo Italiano Malattie EMatologiche dellAdulto July 2015 --

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400/0.5% Tween80/5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Customer Product Validation (2)


Click to enlarge
Rating
Source Cancer Cell 2012 22(5), 656-667 . Ponatinib (AP24534) purchased from Selleck
Method Western blot
Cell Lines RCH-ACV cells
Concentrations 50 nM
Incubation Time 1-24 h
Results Treatment of these cells with a CSK inhibitor (BMS-599626) or a BTK inhibitor (PCI-32765) did not recapitulate the dasatinib/ponatinib phenotype.

Click to enlarge
Rating
Source Genome Biol, 2014, 15(8): 428 . Ponatinib (AP24534) purchased from Selleck
Method Cell Proliferation Assay
Cell Lines KatoIII cells
Concentrations 0-0.5 nM
Incubation Time
Results Each of the inhibitors demonstrated a statistically significant lower IC50 in FGFR2-amplified KatoIII cells compared to non-FGFR2-amplified AGS cells at all concentrations tested.

Product Use Citation (23)

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us